Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 22
- DOI:
- 10.3760/cma.j.issn.0366-6999.20130108
- Key Word:
- microscopic observation drug susceptibility;Mycobacterium tuberculosis;susceptibility test;pyrazinamide
Abstract： Background Drug susceptibility assay is very important in tuberculosis therapy.Pyrazinamide is a first line antituberculosis drug and diagnosis of its resistance in Mycobacterium tuberculosis (M.tuberculosis) is difficult and time consuming by conventional methods.In this study,we aimed to evaluate the performance of the microscopic observation drug susceptibility (MODS) assay in the detection of pyrazinamide resistance in M.tuberculosis relative to the conventional Wayne assay and Lowenstein-Jensen (L J) proportion method.Methods M.tuberculosis clinical isolates (n=132) were tested by the MODS and the Wayne assay:the results were compared with those obtained by the LJ proportion method.Mutations in the gene were identified by direct sequencing of the pncA genes of all isolates in which pyrazinamide resistance was detected by any of the three methods.Results Compared to the LJ results,the sensitivity and specificity of the MODS assay were 97.8％ and 96.5％ respectively; the sensitivity and specificity of the Wayne assay were 87.0％ and 97.7％ respectively.Mutations in the pncA gene were found in 41 of 46 strains that were pyrazinamide resistant (3 tests),in 1 of the 4 strains (LJ only),in 42 of 48 strains (at least 1 test),but no mutations in 1 strain sensitive according to the MODS assay only.The MODS assay,Wayne assay and LJ proportion method provided results in a median time of 6,7 and 26 days respectively.Conclusions MODS assay offers a rapid,simple and reliable method for the detection of pyrazinamide resistance in M.tuberculosis and is an optimal alternative method in resource limited countries.
- [1]Hirata RD,de-Melo FF,Barco P,etc.pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.[J].2006,58(5).
- [2]Chaisson RE,Park WG,Bishai WR,etc.Performance of the Microscopic Observation Drug Susceptibility Assay in Drug Susceptibility Testing for Mycobacterium tuberculosis.[J].2002,40(12).
- [3]M A, Miller,L, Thibert,F, Desjardins,etc.Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay.[J].1995,33.
- [4]K, Konno,F M, Feldmann,W, McDermott.Pyrazinamide susceptibility and amidase activity of tubercle bacilli.[J].1967,95(3).
- [5]Friedland JS,Saravia JC,Gilman RH,etc.Microscopic-observation drug-susceptibility assay for the diagnosis of TB.[J].2006,355(15).
- [6]D, van Soolingen,P W, Hermans,P E, de Haas,etc.Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.[J].1991,29.
- [7]Sheen P,Spellman E,Caviedes L,etc.Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru.[J].2000,38(3).
- [8]Chedore P,Bertucci L,Wolfe.Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.[J].2010,48(1).
- [9]Spositto FL,Leite CQ,Cardoso RF,etc.Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide.[J].2011,17(12).
- [10]A, Scorpio,P, Lindholm-Levy,L, Heifets,etc.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.[J].1997,41.
- [11]L G, Wayne.Simple pyrazinamidase and urease tests for routine identification of mycobacteria.[J].1974,109(1).
- [12]A, Krishnamurthy,D, Almeida,C, Rodrigues,etc.Comparison of pyrazinamide drug susceptibility of M. tuberculosis by radiometric BACTEC and enzymatic pyrazinamidase assay.[J].1900,22(3).
- [13]S.P. Tripathy,D.A. Mitchison,N.G.K. Nair,etc.A comparison of various measures of sensitivity of M. tuberculosis to pyrazinamide[J].1970,51(4).
- [14]Takiff H,Palomino JC,Montoro E,etc.Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.[J].2010,48(8).
- [15]W R, Butler,J O, Kilburn.Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity.[J].1983,24.
- [16]J, Coronel,M, Roper,S, Mitchell,etc.MODS accreditation process for regional reference laboratories in Peru: validation by GenoType? MTBDRplus.[J].2010,14.
- [17]S S, Trivedi,S G, Desai.Pyrazinamidase activity of Mycobacterium tuberculosis--a test of sensitivity to pyrazinamide.[J].1987,68(3).